Showing results (911-920 of 2,363) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|March 27, 2020
Synthesis and evaluation of novel peptidomimetics bearing p-aminobenzoic acid moiety as potential antidiabetic agentsXue-Mei Tang, Wen Hu, Li Fan, et al.
Future Medicinal Chemistry|November 27, 2020
Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge bindersCong-Cong Jia, Wang Chen, Zi-Li Feng, et al.
Future Medicinal Chemistry|January 5, 2021
Advances in the development of connexin hemichannel inhibitors selective toward Cx43Yagya P Subedi, Guillermo A Altenberg, Cheng-Wei T Chang
Future Medicinal Chemistry|December 4, 2020
Whole blood or plasma: what is the ideal matrix for pharmacokinetic-driven drug candidate selection?Ranjeet P Dash, Vijayabhaskar Veeravalli, Jennifer A Thomas, et al.
Future Medicinal Chemistry|December 4, 2020
10 years into the resurgence of covalent drugsElena De Vita
Future Medicinal Chemistry|December 8, 2020
Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compoundsRafael da Fonseca Lameiro, Anwar Shamim, Fabiana Rosini, et al.
Future Medicinal Chemistry|December 9, 2020
Synthesis and activity of BNF15 against drug-resistant Mycobacterium tuberculosisHafij Al Mahmud, Hoonhee Seo, Sukyung Kim, et al.
Future Medicinal Chemistry|September 8, 2022
Bioinspired computational design of lankacidin derivatives for improvement in antitumor activityAhmed Taha Ayoub, Natsumi Nishiura, Aiko Teshima, et al.
Future Medicinal Chemistry|September 30, 2022
Development of a deep learning-based quantitative structure-activity relationship model to identify potential inhibitors against the 3C-like protease of SARS-CoV-2Madhulata Kumari, Naidu Subbarao
Future Medicinal Chemistry|September 27, 2022
Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancerHaijun Gu, Ting Zhang, Yunqi Li, et al.
Pageof 237